Axogen (AXGN) Invested Capital (2010 - 2020)
Axogen's (AXGN) quarterly Invested Capital came in at $35.0 million in Q3 2020, up 1874.06% year-on-year from $1.8 million in Q4 2019, and little changed quarter-over-quarter from $35.0 million in Q2 2020.
Axogen (AXGN) Invested Capital (2010 - 2020) Analysis & Trends
Axogen's Invested Capital history runs 8 years deep, the most recent figure standing at $35.0 million for Q3 2020.
- On a quarterly basis, Invested Capital rose 1874.06% year-over-year to $35.0 million in Q3 2020; TTM through Jun 2021 was $35.0 million, a 13.14% decrease from a year earlier, with the FY2019 full-year figure at $1.7 million, up 6100.0% from the prior year.
- Invested Capital held at $35.0 million in Q3 2020 per AXGN's latest filing, from $35.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $35.0 million in Q2 2020 and bottomed at $20899.0 in Q4 2016.
- The 5-year median for Invested Capital is $1.0 million (2017), against an average of $5.2 million.
- Biggest YoY gain for Invested Capital was 17283.97% in 2018; the steepest drop was 96.19% in 2018.
- Year by year, Invested Capital stood at $20899.0 in 2016, then soared by 3416.91% to $735000.0 in 2017, then slumped by 96.19% to $28000.0 in 2018, then jumped by 6100.0% to $1.7 million in 2019, then surged by 1916.13% to $35.0 million in 2020.
- Per Business Quant, the three latest AXGN Invested Capital figures stand at $35.0 million (Q3 2020), $35.0 million (Q2 2020), and $1.8 million (Q1 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 7.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | 15.00 Mn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 1.41 Bn |
| 10 | Axogen | 2.11 Bn | 2.01 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 35.00 Mn |
| Jun 30, 2020 | 35.00 Mn |
| Mar 31, 2020 | 1.79 Mn |
| Dec 31, 2019 | 1.74 Mn |
| Sep 30, 2019 | 1.77 Mn |
| Jun 30, 2019 | 1.83 Mn |
| Mar 31, 2019 | 1.36 Mn |
| Dec 31, 2018 | 28,000.00 |
| Sep 30, 2018 | 35,962.00 |
| Jun 30, 2018 | 39,028.00 |
| Mar 31, 2018 | 3.98 Mn |
| Dec 31, 2017 | 735,000.00 |
| Sep 30, 2017 | 21,596.00 |
| Jun 30, 2017 | 24,947.00 |
| Mar 31, 2017 | 22,913.00 |
| Dec 31, 2016 | 20,899.00 |
| Sep 30, 2012 | -1.89 Mn |
| Jun 30, 2012 | 1.40 Mn |
| Mar 31, 2012 | 918,480.00 |
| Dec 31, 2011 | 434,734.00 |